Snowball logo
logo
MRVL

Marvel Biosciences Corp

CA$0.16CA$0.00  (0%)
Estimate
EPS
-0.03
Beta
0.592
Growth
Net income, YoY
269.65%
FCF, YoY
130.89%
About the company
Ticker
MRVL
ISIN
CA57384M1077
Country
Canada
Sector (GICS)
Healthcare
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.

Frequently asked questions

What sector does Marvel Biosciences Corp (MRVL) operate in?

Marvel Biosciences Corp belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Marvel Biosciences Corp (MRVL) current stock price?

As of the latest data, Marvel Biosciences Corp stock price is CA$0.16, with a previous close of CA$0.16.

What is Marvel Biosciences Corp (MRVL) current market capitalization?

Marvel Biosciences Corp market cap is approximately 10.08 million.

What is Marvel Biosciences Corp (MRVL) Earnings Per Share (EPS)?

The trailing EPS is -CA$0.03.

Does Marvel Biosciences Corp (MRVL) pay dividends?

No. Marvel Biosciences Corp does not pay a dividend.

When is Marvel Biosciences Corp (MRVL) next earnings report?

Marvel Biosciences Corp is expected to release its next earnings report on October 31, 2026.

What is Marvel Biosciences Corp (MRVL) beta (volatility) score?

Marvel Biosciences Corp has a beta of 0.592, indicating lower volatility than the overall market.